As the global economy mends, the 2021 growth of Clinical Biomarker Testing will have significant change from previous year. According to our (LP Information) latest study, the global Clinical Biomarker Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Clinical Biomarker Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Clinical Biomarker Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Clinical Biomarker Testing market, reaching US$ million by the year 2028. As for the Europe Clinical Biomarker Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Clinical Biomarker Testing players cover Abbott Laboratories, AbbVie Inc., Adaptive Biotechnologies, and Agilent Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Biomarker Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific